Zingiberene, a non-zinc-binding class I HDAC inhibitor: A novel strategy for the management of neuropathic pain.
The researchers explored the potential of a rhizome extract from Zingiber officinalis in inhibiting HDAC1 to reduce neuroinflammation. This could lead to more selective and effective treatments for neurodegenerative diseases.
- Borgonetti V et al (2023).
- Phytomedicine.
- PubMed:
- 36681053